UROMEMS

Science behind it. Life ahead of it.

UROMEMS was founded in 2011, is headquartered in Grenoble, France, lists 11–50 employees, and has $134.3M in recorded funding across 4 rounds.

Headquarters
Grenoble
Employees
11–50
Founded
2011
Business Model
B2B
Total Funding
$134.3M
Last Round
$60.0M Corporate RoundMar 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 3 investors for this company. The full record is or through the API.

About

UroMems is a global medtech company co-founded in 2011 by Professor Pierre Mozer, Hamid Lamraoui, and Stéphane Lavallée, developing UroActive — the first smart, automated artificial urinary sphincter (AUS) implant for the treatment of stress urinary incontinence in both women and men. The active implantable device leverages embedded systems and micro-technologies to remotely adjust to each patient's individual needs, improving quality of life without manual patient intervention. UroMems has completed first-in-human feasibility studies in both female and male patients and received FDA IDE approval in 2025 to advance pivotal clinical trials.

Summary

UROMEMS is a Biotech company based in Grenoble, France, founded in 2011. It lists 11–50 employees. It has raised $134.3M in total across 4 rounds, most recently a $60.0M Corporate Round in Mar 2025. Investors include Ajax Health, Crédit Mutuel Innovation and European Innovation Council Fund.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundMar 2025
$60.0M

Sign up to see all 4 events

Funding: Series B through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

UROMEMS on Indexed.vc
<a href="https://indexed.vc/companies/uromems"><img src="https://indexed.vc/api/badge/company/uromems" alt="UROMEMS on Indexed.vc" width="260" height="76" /></a>